SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 13 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 2,000 | -50.0% | 0.00% | -100.0% |
| Q3 2018 | $7,000 | 0.0% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $7,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | -22.2% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | -25.0% | 4,000 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $12,000 | -33.3% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $18,000 | -5.3% | 4,000 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $19,000 | -20.8% | 4,000 | 0.0% | 0.01% | -36.4% |
| Q4 2016 | $24,000 | +9.1% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $22,000 | +46.7% | 4,000 | 0.0% | 0.01% | +37.5% |
| Q2 2016 | $15,000 | +150.0% | 4,000 | +100.0% | 0.01% | +166.7% |
| Q1 2016 | $6,000 | -45.5% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $11,000 | 0.0% | 2,000 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $11,000 | -35.3% | 2,000 | 0.0% | 0.01% | -30.0% |
| Q2 2015 | $17,000 | +88.9% | 2,000 | 0.0% | 0.01% | +100.0% |
| Q1 2015 | $9,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
| Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
| Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
| KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
| Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
| Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
| Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
| Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |